Susan Cornell: Well, things come to mind, I guess I’m going to put this into 2 categories. I’m going to put this into medications and therapy options, and then I’m…
Tag: Annual
Blueprint Medicines to Showcase Broad Precision Therapy Pipeline at AACR Annual Meeting 2022
— Blueprint Medicines to host investor conference call and webcast on Friday, April 8, 2022 — CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ — Blueprint Medicines Corporation (NASDAQ: BPMC) today announced…
FDA Approves 2-Dose Annual Inclisiran to Lower Cholesterol
The approval marks the first small interfering RNA therapy for low-density lipoprotein cholesterol reduction. Inclisiran (Leqvio; Novartis) has become the first small interfering RNA (siRNA) therapy to be approved by…
Scholar Rock to Present New Apitegromab Data Including 24-Month Efficacy and Safety Data from TOPAZ Phase 2 Trial at the 2022 Annual Cure SMA Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that the…
Karmanos Cancer Institute and the Detroit Tigers honor survivors and promote breast health at 10th Annual Pink Out the Park game
Throughout the game and in the Comerica Park concourse, fans will have the opportunity to engage with several activities, including a ceremonial first pitch, in-game awareness promotions, and an on-field…